This document summarizes India's National AIDS Control Programme (NACP). It recommends treating all HIV patients with antiretroviral therapy (ART) regardless of disease stage or CD4 count. First line ART combines two nucleoside reverse-transcriptase inhibitors (NRTIs) with a non-nucleoside reverse-transcriptase inhibitor (NNRTI). Alternative and second line ART are used if first line treatment fails or causes toxicity. It also describes management of opportunistic infections, sexually transmitted diseases (STDs), and education programs for adolescents and college students to increase HIV/AIDS awareness and prevention.